We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$2.88B
AUM Growth
-$192M
Cap. Flow
-$389M
Cap. Flow %
-13.48%
Top 10 Hldgs %
24.09%
Holding
2,616
New
690
Increased
430
Reduced
710
Closed
773

Top Buys

Rank Stock Value
1
XPEV icon
XPeng
XPEV
+$75.5M
2
BEKE icon
KE Holdings
BEKE
+$46.5M
3
NTES icon
NetEase
NTES
+$45.4M
4
EDU icon
New Oriental
EDU
+$39.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Consumer Discretionary 7.29%
3 Communication Services 3.78%
4 Financials 3.51%
5 Healthcare 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
1551
American Well
AMWL
$230M
$18K ﹤0.01%
+147
New +$22.4K
BCAB icon
1552
BioAtla
BCAB
$5.74M
$18K ﹤0.01%
18
-43
-70% -$55K
BDC icon
1553
Belden
BDC
$5.19B
$18K ﹤0.01%
+274
New +$17.2K
BRC icon
1554
Brady Corp
BRC
$4.57B
$18K ﹤0.01%
335
-925
-73% -$48.5K
CIEN icon
1555
Ciena
CIEN
$58.4B
$18K ﹤0.01%
231
-28,628
-99% -$1.77M
ILPT
1556
Industrial Logistics Properties Trust
ILPT
$586M
$18K ﹤0.01%
705
-328
-32% -$8.29K
LVLU icon
1557
Lulu's Fashion Lounge
LVLU
$52.3M
$18K ﹤0.01%
+120
New +$22K
OSIS icon
1558
OSI Systems
OSIS
$3.89B
$18K ﹤0.01%
+190
New +$17.8K
RCUS icon
1559
Arcus Biosciences
RCUS
$3.64B
$18K ﹤0.01%
+449
New +$17.4K
REVG
1560
DELISTED
REV Group
REVG
$18K ﹤0.01%
1,274
+630
+98% +$9.96K
RIGL icon
1561
Rigel Pharmaceuticals
RIGL
$750M
$18K ﹤0.01%
687
-117
-15% -$3.53K
RNAC icon
1562
Cartesian Therapeutics
RNAC
$268M
$18K ﹤0.01%
182
-9
-5% -$968
HTB
1563
HomeTrust Bancshares
HTB
$848M
$18K ﹤0.01%
+592
New +$17.9K
CUTR
1564
DELISTED
Cutera, Inc.
CUTR
$18K ﹤0.01%
428
+163
+62% +$6.68K
NGM
1565
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$18K ﹤0.01%
+1,003
New +$19.2K
EAR
1566
DELISTED
Eargo, Inc. Common Stock
EAR
$18K ﹤0.01%
179
-543
-75% -$70.6K
FORR icon
1567
Forrester Research
FORR
$224M
$17K ﹤0.01%
+296
New +$16.5K
FULC icon
1568
Fulcrum Therapeutics
FULC
$297M
$17K ﹤0.01%
+982
New +$19.5K
IDYA icon
1569
IDEAYA Biosciences
IDYA
$3.56B
$17K ﹤0.01%
+728
New +$16.9K
NVRI icon
1570
Enviri
NVRI
$620M
$17K ﹤0.01%
1,031
QTTB icon
1571
Q32 Bio
QTTB
$464M
$17K ﹤0.01%
+264
New +$25.6K
TPC
1572
Tutor Perini Cor
TPC
$5.21B
$17K ﹤0.01%
1,401
+1,144
+445% +$15.3K
AEL
1573
DELISTED
American Equity Investment Life Holding Company
AEL
$17K ﹤0.01%
436
-327
-43% -$11.4K
BNFT
1574
DELISTED
Benefitfocus, Inc.
BNFT
$17K ﹤0.01%
+1,578
New +$16.9K
CDZI icon
1575
Cadiz
CDZI
$291M
$16K ﹤0.01%
4,090
-3,473
-46% -$18.8K

Similar funds

Point72 Hong Kong's Q4 2021 Portfolio in Review

As of Q4 2021, Point72 Hong Kong held 2,616 positions worth $2.88B, down 6.2% from $3.08B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Point72 Hong Kong withdrew a net $389M in Q4 2021, closing 773 positions and reducing 710 holdings. Its most notable exit was TAL Education Group, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Point72 Hong Kong opened a new position in Riot Platforms worth $20.5M.

  • Point72 Hong Kong's largest Q4 2021 buy was Riot Platforms: 920,169 shares worth $20.5M.
  • Point72 Hong Kong added most to XPeng in Q4 2021, an estimated $75.5M increase.
  • Point72 Hong Kong's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $25.5M.
  • Point72 Hong Kong fully exited TAL Education Group in Q4 2021, selling an estimated $37M.
  • Point72 Hong Kong's ten largest holdings make up 24% of its $2.88B portfolio in Q4 2021.
  • Point72 Hong Kong opened 690 new positions and closed 773 in Q4 2021.
  • Point72 Hong Kong's portfolio value fell 6.2% quarter-over-quarter to $2.88B.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.